Avances en Medicina
Uso de digoxina en pacientes con fibrilación auricular y resultados cardiovasculares adversos: un análisis retrospectivo de rivaroxabán oral directo del factor Xa inhibición una vez al día en comparación con el antagonismo de la vitamina K para la prevención del ictus y de la embolia en la fibrilación auricular (ROCKET AF)
Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: A retrospective analysis of the rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF)
Leído
30785
Vecesse ha leído el artículo
3543
Total PDF
27242
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 91 | 8 | 99 |
| 2025 11 | 366 | 43 | 409 |
| 2025 10 | 411 | 21 | 432 |
| 2025 9 | 365 | 27 | 392 |
| 2025 8 | 371 | 27 | 398 |
| 2025 7 | 393 | 13 | 406 |
| 2025 6 | 463 | 17 | 480 |
| 2025 5 | 484 | 23 | 507 |
| 2025 4 | 556 | 30 | 586 |
| 2025 3 | 558 | 40 | 598 |
| 2025 2 | 481 | 37 | 518 |
| 2025 1 | 566 | 18 | 584 |
| 2024 12 | 530 | 26 | 556 |
| 2024 11 | 537 | 29 | 566 |
| 2024 10 | 593 | 64 | 657 |
| 2024 9 | 511 | 26 | 537 |
| 2024 8 | 482 | 33 | 515 |
| 2024 7 | 483 | 26 | 509 |
| 2024 6 | 502 | 32 | 534 |
| 2024 5 | 574 | 30 | 604 |
| 2024 4 | 517 | 49 | 566 |
| 2024 3 | 435 | 29 | 464 |
| 2024 2 | 398 | 28 | 426 |
| 2024 1 | 557 | 40 | 597 |
| 2023 12 | 436 | 28 | 464 |
| 2023 11 | 593 | 47 | 640 |
| 2023 10 | 540 | 41 | 581 |
| 2023 9 | 386 | 34 | 420 |
| 2023 8 | 414 | 29 | 443 |
| 2023 7 | 395 | 41 | 436 |
| 2023 6 | 421 | 39 | 460 |
| 2023 5 | 595 | 34 | 629 |
| 2023 4 | 432 | 34 | 466 |
| 2023 3 | 372 | 26 | 398 |
| 2023 2 | 281 | 20 | 301 |
| 2022 1 | 229 | 15 | 244 |
| 2022 12 | 212 | 19 | 231 |
| 2022 11 | 306 | 15 | 321 |
| 2022 10 | 256 | 14 | 270 |
| 2022 9 | 215 | 30 | 245 |
| 2022 8 | 214 | 32 | 246 |
| 2022 7 | 230 | 19 | 249 |
| 2022 6 | 233 | 18 | 251 |
| 2022 5 | 175 | 15 | 190 |
| 2022 4 | 247 | 34 | 281 |
| 2022 3 | 202 | 20 | 222 |
| 2022 2 | 197 | 24 | 221 |
| 2021 1 | 195 | 28 | 223 |
| 2021 12 | 158 | 36 | 194 |
| 2021 11 | 205 | 30 | 235 |
| 2021 10 | 248 | 30 | 278 |
| 2021 9 | 170 | 26 | 196 |
| 2021 8 | 173 | 28 | 201 |
| 2021 7 | 205 | 29 | 234 |
| 2021 6 | 154 | 19 | 173 |
| 2021 5 | 206 | 30 | 236 |
| 2021 4 | 361 | 47 | 408 |
| 2021 3 | 237 | 14 | 251 |
| 2021 2 | 146 | 16 | 162 |
| 2020 1 | 176 | 19 | 195 |
| 2020 12 | 129 | 12 | 141 |
| 2020 11 | 160 | 26 | 186 |
| 2020 10 | 125 | 22 | 147 |
| 2020 9 | 158 | 20 | 178 |
| 2020 8 | 147 | 22 | 169 |
| 2020 7 | 120 | 15 | 135 |
| 2020 6 | 115 | 12 | 127 |
| 2020 5 | 134 | 27 | 161 |
| 2020 4 | 142 | 19 | 161 |
| 2020 3 | 132 | 32 | 164 |
| 2020 2 | 148 | 25 | 173 |
| 2020 1 | 150 | 28 | 178 |
| 2019 12 | 136 | 27 | 163 |
| 2019 11 | 119 | 31 | 150 |
| 2019 10 | 194 | 21 | 215 |
| 2019 9 | 175 | 33 | 208 |
| 2019 8 | 151 | 16 | 167 |
| 2019 7 | 107 | 44 | 151 |
| 2019 6 | 146 | 79 | 225 |
| 2019 5 | 359 | 144 | 503 |
| 2019 4 | 209 | 90 | 299 |
| 2019 3 | 87 | 82 | 169 |
| 2019 2 | 91 | 44 | 135 |
| 2019 1 | 82 | 28 | 110 |
| 2018 12 | 72 | 21 | 93 |
| 2018 11 | 85 | 55 | 140 |
| 2018 10 | 184 | 18 | 202 |
| 2018 9 | 100 | 33 | 133 |
| 2018 8 | 59 | 53 | 112 |
| 2018 7 | 76 | 51 | 127 |
| 2018 6 | 86 | 43 | 129 |
| 2018 5 | 129 | 58 | 187 |
| 2018 4 | 144 | 41 | 185 |
| 2018 3 | 121 | 36 | 157 |
| 2018 2 | 71 | 12 | 83 |
| 2018 1 | 71 | 14 | 85 |
| 2017 12 | 69 | 16 | 85 |
| 2017 11 | 93 | 15 | 108 |
| 2017 10 | 99 | 16 | 115 |
| 2017 9 | 83 | 27 | 110 |
| 2017 8 | 87 | 19 | 106 |
| 2017 7 | 57 | 20 | 77 |
| 2017 6 | 73 | 52 | 125 |
| 2017 5 | 75 | 36 | 111 |
| 2017 4 | 50 | 61 | 111 |
| 2017 3 | 31 | 53 | 84 |
| 2017 2 | 41 | 60 | 101 |
| 2016 1 | 25 | 12 | 37 |
| 2016 12 | 29 | 23 | 52 |
| 2016 11 | 50 | 24 | 74 |
| 2016 10 | 60 | 17 | 77 |
| 2016 9 | 72 | 21 | 93 |
| 2016 8 | 38 | 18 | 56 |
| 2016 7 | 40 | 9 | 49 |
| 2016 6 | 5 | 5 | 10 |
| 2016 5 | 12 | 9 | 21 |
Mostrar todo
